design and results of pacritinib for myelofibrosis trial (persist-1)
Published 9 years ago • 70 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
2:04
design and results of persist-1 trial of pacritinib for myelofibrosis
-
2:18
results of persist-1 & persist-2 studies of pacritinib vs best alternative therapy in myelofibrosis
-
3:46
results of the phase iii persist-1 trial of pacritinib for myelofibrosis
-
2:18
updates on persist-1 trial of pacritinib for myelofibrosis
-
1:17
the use of pacritinib in thrombocytopenic patients with myelofibrosis undergoing allosct
-
1:46
the efficacy of pacritinib in patients with myelofibrosis who have both thrombocytopenia and anemia
-
0:54
study design for persist-2 and other upcoming trials of pacritinib
-
1:15
potential approval of pacritinib for the treatment of myelofibrosis
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
14:40
primary myelofibrosis (pmf)
-
4:35
updated safety & efficacy data from manifest-2: pelabresib plus ruxolitinib for myelofibrosis
-
2:05
investigating the efficacy of tp-3654 in patients with myelofibrosis: results from phase i study
-
5:45
advance iv results: efficacy and safety of intravenous efgartigimod in adults with primary itp
-
1:28
indirect comparison of momelotinib vs pacritinib safety and anemia outcomes in myelofibrosis
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
4:35
pacritinib moving forwards for myelofibrosis
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
4:25
update on momelotinib for myelofibrosis
-
1:13
selecting conditioning regimens for patients with myelofibrosis undergoing allosct
-
1:01
latest advances in myelofibrosis treatment